Delineation of neutralizing antibody specificity from vaccine and placebo recipients at 1 and 3 years post-diagnosis.

Thirty viruses were used to predict the specificity of the neutralizing antibodies with a neutralization breadth >30%. Epitope specificities were designated for each algorithm if the value was >0.3 for the respective monoclonal antibodies. If no specificity gave a value >0.3, the sample was designated as ‘unspecified’. The table was sorted by treatment group and time from diagnosis. (XLSX)